Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

BIO-GENE TECHNOLOGY LTD

INVESTOR PRESENTATION - BIO-GENE TECHNOLOGY LTD

ASX:BGT

BIO-GENE TECHNOLOGY LTD

Materials

Bio-Gene Technology Ltd (BGT) is an Australian public biotechnology company that is developing a patent protected product platform as a new class of insecticides. Bio-Gene owns patents covering the use of these -triketone insecticides for insect control. Bio-Gene's is developing two products targeted at different sectors of the insecticide market. The natural product Qcide - is an oil extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana). This product is focused on organic insect control. FLAVOCIDE - is a chemically synthesised product developed as a nature identical molecule to molecules also found in Eucalyptus cloeziana extracts.

Read more

Market Cap

$19.71m

Price at Close

$0.13

4w avg. Volume

326.55k

4w avg. Turnover

$46.71k

Announcements
announcementt+2 movementdate
  • Amended Constitution

    Company Administration

  • -

    26 Nov 2020

-

26 Nov 2020
  • Final Director's Interest Notice

    Shareholder Details

  • -

    26 Nov 2020

-

26 Nov 2020
  • Final Director's Interest Notice

    Shareholder Details

  • -

    26 Nov 2020

-

26 Nov 2020
  • Retirement of Directors

    Company Administration

  • -

    26 Nov 2020

-

26 Nov 2020
  • Results of Meeting

    Notice Of Meeting · Market sensitive

  • -

    26 Nov 2020

-

26 Nov 2020
  • Bio-Gene 2020 AGM - CEO's Address

    Chairman's Address · Market sensitive

  • -7.14%

    25 Nov 2020

-7.14%

25 Nov 2020
  • Bio-Gene 2020 AGM - Meeting Chairman's Address

    Chairman's Address · Market sensitive

  • -7.14%

    25 Nov 2020

-7.14%

25 Nov 2020
  • Bio-Gene 2020 AGM Presentation

    Periodic Reports · Market sensitive

  • -7.14%

    25 Nov 2020

-7.14%

25 Nov 2020
  • Trading Halt

    Stock Exchange Announcement · Market sensitive

  • -7.14%

    25 Nov 2020

-7.14%

25 Nov 2020
  • 2020 AGM - Withdrawal of Resolutions

    Notice Of Meeting

  • 0.00%

    18 Nov 2020

0.00%

18 Nov 2020
Market Data

Current Price

$0.13

52WK HIGH

$0.32

52WK LOW

$0.1

1YR RETURN

-10.34%

1YR RETURN VS. SECTOR

+9.64%

90 DAY RETURN

-3.70%

ASX RANK

1,474

/2,026

SECTOR RANK

6

/8

SHARES OUTSTANDING

151.61m
ASX:BGT

BIO-GENE TECHNOLOGY LTD

Materials

Bio-Gene Technology Ltd (BGT) is an Australian public biotechnology company that is developing a patent protected product platform as a new class of insecticides. Bio-Gene owns patents covering the use of these -triketone insecticides for insect control. Bio-Gene's is developing two products targeted at different sectors of the insecticide market. The natural product Qcide - is an oil extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana). This product is focused on organic insect control. FLAVOCIDE - is a chemically synthesised product developed as a nature identical molecule to molecules also found in Eucalyptus cloeziana extracts.

Read more

Market Cap

$19.71m

Price at Close

$0.13

4w avg. Volume

326.55k

4w avg. Turnover

$46.71k

ASX:BGT is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.